Patents by Inventor Melissa MYINT

Melissa MYINT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS TO STIMULATE HLA-AGNOSTIC IMMUNE RESPONSES TO PROTEINS USING NUCLEATED CELLS
    Publication number: 20230263879
    Abstract: The present application provides nucleated cells comprising a protein or fragment thereof, methods of manufacturing such nucleated cells comprising the protein or fragment thereof, and methods of using such modified nucleated cells (e.g., immune cells) for stimulating an immune response in a HLA agnostic manner.
    Type: Application
    Filed: September 1, 2021
    Publication date: August 24, 2023
    Applicant: SQZ Biotechnologies Company
    Inventors: Emrah Ilker OZAY, Michael MALONEY, Scott LOUGHHEAD, Howard BERNSTEIN, Katherine SEIDL, Melissa MYINT, Armon R. SHAREI
  • INTRACELLULAR DELIVERY OF BIOMOLECULES TO ENHANCE ANTIGEN PRESENTING CELL FUNCTION
    Publication number: 20210388390
    Abstract: The present application provides enhanced antigen presenting cells comprising an agent that enhances the viability and/or function of the antigen presenting cell and/or an antigen and/or an adjuvant, methods of manufacturing such modified antigen presenting cells, and methods of using such modified antigen presenting cells, such as for modulating an immune response in an individual.
    Type: Application
    Filed: October 3, 2019
    Publication date: December 16, 2021
    Inventors: Howard BERNSTEIN, Matt BOOTY, Luke CASSEREAU, Jonathan CHOW, Kelan HLAVATY, Scott LOUGHHEAD, Melissa MYINT, Scott SAUER, Armon SHAREI, Vidhya VIJAYAKUMAR
  • METHODS FOR TREATING HPV-ASSOCIATED DISEASES
    Publication number: 20210038709
    Abstract: The present application provides immune cells comprising an HPV antigen and an adjuvant, methods of manufacturing such modified immune cells, and methods of using such modified immune cells for treating an HPV-associated disease, preventing an HPV-associated disease and/or for modulating an immune response in an individual with an HPV-associated disease.
    Type: Application
    Filed: March 11, 2019
    Publication date: February 11, 2021
    Inventors: Scott LOUGHHEAD, LeeAnn TALARICO, Alfonso VICENTE-SUAREZ, Matt BOOTY, Howard BERNSTEIN, Katarina BLAGOVIC, Armon R. SHAREI, Kelan HLAVATY, Melissa MYINT